期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 224, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2021.113681
关键词
HIV; gp120; Drug discovery; Lead optimization; Synthesis; Screening
资金
- NIH [R01 AI104416]
- New York Blood Center
Development of alternative scaffolds and validation of synthetic pathways as tools for exploring new HIV gp120 inhibitors based on NBD-14136. New synthetic routes were guided by molecular modeling and chemical analysis, and representative compounds were tested for inhibition and cell viability.
We present the development of alternative scaffolds and validation of their synthetic pathways as a tool for the exploration of new HIV gp120 inhibitors based on the recently discovered inhibitor of this class, NBD-14136. The new synthetic routes were based on isosteric replacements of the amine and acid precursors required for the synthesis of NBD-14136, guided by molecular modeling and chemical feasibility analysis. To ensure that these synthetic tools and new scaffolds had the potential for further exploration, we eventually tested few representative compounds from each newly designed scaffold against the gp120 inhibition assay and cell viability assays. (C) 2021 Published by Elsevier Masson SAS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据